Flu update: Why molecular is the right method for respiratory testing

October 16, 2020

Watch this webinar to see the current state of flu and group A strep in the U.S., review the latest guidelines and recommendations and assess the benefits of molecular testing in CLIA waived settings.

Webinar originally aired on January 15, 2020

Flu update: Why molecular is the right method for respiratory testing

New Vaccines Offer Hope in the Fight Against RSV

RSV FAQs: What Providers Need to Know About the New RSV Vaccines

Do more for your CPAP patients while helping grow your revenue

Testing in a pandemic: How health systems can prepare for this respiratory season

Strategies for pediatricians to debunk common vaccine myths

Guide to respiratory therapy products

The roadmap to respiratory season success in non-acute settings

The case for PCR in your practice

Flu prevention strategies for the 2021-2022 season

Support better patient outcomes with point-of-care testing

COVID-19 related conditions: Care & product guide

QuickVue® At-Home OTC COVID-19 Test

User instructions for the Quidel® QuickVue® At-Home COVID-19 Test

Introducing the Quidel® QuickVue® At-Home OTC COVID-19 Test

Why choose McKesson for your CPAP resupplies?

McKesson VerbalCare®

The respiratory supply chain: More critical than ever

Diagnosing COVID-19 & influenza types A+B during the pandemic

A timely seasonal update on respiratory testing in primary & urgent care

Point-of-care lab testing methods for COVID-19 & respiratory illnesses